Role of Biotechnology and Pharmaceutical Companies in Developing Novel Therapies for Female Sexual Dysfunction

Female sexual disorders have historically been treated with multiple non-medical and off-label medical therapies by a limited number of experienced clinicians. Yet, most therapies have insufficient clinical evidence to support their safety and efficacy. Thus, the development of safe and effective therapies for the treatment of sexual disorders in women is critical to improving the overall management of these conditions, and increasing access to care. The International Society for the Study of Women’s Sexual Health (ISSWSH) supports the role of biotechnology and pharmaceutical companies, and other investigators developing novel therapies for female sexual dysfunction. ISSWSH rejects a “one size fits all” approach to treating female sexual dysfunction due to the multiplicity of biopsychosocial factors that impact sexual health. The concept of personalized medicine, and the availability of multiple therapeutic options are critical in this field.

Save the Date

ISSWSH Sexual Pain Course 2020
April 17-18, 2020
CANCELLED DUE TO COVID-19
Read more...

ISSWSH Fall Course 2020
November 19-21, 2020   235 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

ISSWSH Annual Meeting 2021
March 4-7, 2021   340 days left
Renaissance Dallas Hotel, Dallas, TX, USA

Latest Tweets

“No research can be truly meaningful if there is not a regulatory agency that will allow developers to put forward… https://t.co/lGlT88qH4U ISSWSH
Time to Orgasm in Women in a Monogamous Stable Heterosexual Relationship was 13 minutes in this study. https://t.co/3ovAvTUcRa ISSWSH
Endometriosis apps include symptom trackers, education, & support for women w/this condition. Do apps have a role i… https://t.co/4T9KMOVJm3 ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on Twitter!